News Roche Holding AG

Stocks

ROP

CH1499059983

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 09:01:48 14/07/2026 pm IST			5-day change	1st Jan Change
327.00 ^CHF	-1.12%		-3.68%	-0.37%

14/07	Swiss Market Index Slips; Roche Shares Down	MT
14/07	Where would AI lead Pharma in the long run?

All News

Mentions Relevance

14/07	Roche Introduces Cobas Hepatitis D Virus Test for Use on Cobas 5800/6800/8800 Systems	CI
14/07	Roche launches a Cobas test for the hepatitis D virus
14/07	Roche Introduces Fully Automated Hepatitis D Virus Test	MT
09/07	Roche's Tuberculosis Test Receives CE Mark	MT
08/07	ABB Robotics Partners with Roche Diagnostics	MT
07/07	Roche Presents New Data in Alzheimer?S Disease Portfolio At Aaic 2026	CI
07/07	Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC	BU
06/07	HSBC Downgrades Roche to Hold Rating	MT
02/07	Roche Reports Positive Results from Phase Iii Krascendo 1 Study Evaluating Divarasib Against Approved Kras G12c Inhibitors in Previously Treated Kras G12c Non-Small Cell Lung Cancer	CI
02/07	Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial	DJ
02/07	Roche's Non-small Cell Lung Cancer Drug Meets Primary, Key Secondary Endpoint in Late-stage Trial	MT
02/07	Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer	BU
30/06	FDA grants Priority Review to Roche's Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)	AQ
30/06	ROCHE HOLDINGS AG : Goldman Sachs sticks Neutral	ZD
30/06	Roche Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Enspryng for Thyroid Eye Disease	CI
30/06	Roche Receives US Priority Review Status for Thyroid Eye Disease Treatment	MT
30/06	FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)	BU
29/06	Excalipoint Therapeutics And Roches Announce Clinical Trial Collaboration To Evaluate EXP011 In DLL3-Expressing Solid Tumors	CI
29/06	Roche takes aim at Illumina's dominance with new gene sequencing machine	RE
29/06	Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip	RE
29/06	Roche Announces Launch Of AXELIOS 1 Sequencing Platform	CI
29/06	Switzerland's Roche Introduces New Sequencing Platform	MT
25/06	Roche Holding AG Announces FDA Grants Priority Review Status to its Atezolizumab for Treatment of Certain Type of Stage III Colorectal Cancer	CI
18/06	FDA Approves First Generic Single-Dose Flu Treatment	DJ
18/06	Roche Receives FDA Acceptance for Supplemental Biologics License Application For Lunsumio And Polivy Combination For Relapsed Or Refractory Large B-Cell Lymphoma	CI